Education
Ph.D. Pathobiology
Johns Hopkins University, 2022
M.S. Biochemistry and Molecular Biology
Johns Hopkins University, 2018
B.S. Chemistry
Morgan State University, 2011
Selected Experience
Covaris - Field Application Scientist
June 2022 - Present
- Provide technical expertise and customer education for Genomics, Epigenetics, and Proteomics workflow solutions
- Create and manage technical resources and scientific collaborations
- Liaise between customers, Sales, Marketing, R&D and customers
- Partner with Sales team and serve as a technical expert to drive sales and provide technical support
- Arrange and perform demonstration of company’s products and their applications
PathoVax - Research Specialist
July 2018 - April 2019
- Produce Human papillomavirus (HPV) viral-like particles (VLPs) and pseudoviruses (PsV) in suspension and adherent cells
- Mouse in vivo challenge with various types of HPV PsVs
- Mouse in vivo imaging using IVIS spectrum imaging system
Johns Hopkins University, Bloomberg School of Public Health - Research Assistant
August 2013 - March 2018
- Maintain, manipulate, immunoblot and immunostain mammalian cells
- Develop mitochondrial isolation assay preserving mitochondria-ER contacts
- Collect, culture and immunostain prophase I oocytes
- Microinject mammalian oocytes
University of Maryland, School of Medicine - Research Assistant
February 2012 - February 2013
- Prepare and analyze immunohistochemical samples
- Compile and analyze research data using graphing and statistical analysis software
Summer Internships
- New York University (2011)
- Sligo Institute of Technology, School of Science Sligo, Ireland (2010)
- Johns Hopkins University, Bloomberg School of Public Health (2009)
Selected Courses
ME100.710:
Biochemical and Biophysical principles
•
ME260.709:
Molecular Biology and Genomics
•
ME:100.709:
Macromolecular Structure and Analysis
•
ME:110.728:
Cell Structure and Dynamics
•
ME:110.733:
Principles of Genetics
•
ME:250.703:
Graduate Immunology
•
ME:260.709:
Molecular Biology and Genomics
•
ME:300.710:
Pathobiology and Disease Mechanisms
•
ME:300.714:
Pathology for Graduate Students: Cancer
•
ME:300.715:
Pathology for Graduate Students: Neuropathology
•
ME:300.716:
Pathology for Graduate Students: Immunology/Infectious Disease
•
ME:360.728:
Pathways and Regulation
•
ME:800.707:
Computational Biology and Bioinformatics
•
PH.120.840:
Biochemistry
•
PH.120.850:
Biochemical Techniques
•
PH.120.852:
Core Research Literature
•
PH120.624:
Genome Integrity and Cancer
•
PH140.611/612:
Statistical reasoning in Public Health 1 / 2
Selected Publications
- Olczak P, Roden R (2020) "Progress in L2-based prophylactic vaccine development for protection against diverse human papillomavirus genotypes and associated diseases." Vaccines
- S Mandal SK, Banerjee HN, Vaughan D, Boston A, Thorne G , Payne G, Sampson J, Manglik V , Olczak P , et al., (2018) "The Effects of Synthesized Rhenium Acetylsalicylate Compounds on Human Astrocytoma Cell Lines." Journal of Cancer Science and Therapy
- Wilder PT, Weber DJ, Winstead A, Parnell S, Hinton TV, Stevenson M, Giri D, Azemati S, Olczak P et al., (2017) "Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA-MB-231 breast cancer cells." Molecular Cellular Biochemistry.
- Olczak P, Wong M, Tsai HL, Wang H, Kirnbauer R, Griffith AJ, Lambert PF, Roden R. Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice. Virology. 2022;575.
- Olczak P, Matsui K, Wong M, Alvarez J, Lambert P, Christensen ND, Hu J, Huber B, Kirnbauer R, Wang JW, Roden RBS. RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer. J Virol. 2022;96(13).
